Results 221 to 230 of about 370,457 (256)
Some of the next articles are maybe not open access.

Epigenetic Regulation Towards Acquired Drug Resistance in Cancer

2022
Therapy resistance remains the most challenging obstacle in cancer treatment. Substantial efforts and evidences have accumulated over decades suggesting not only genetic but non-genomic mechanisms underlying this adaptation of tumor cells. Alterations in epigenome can have a fundamental effect on cellular functions and response to stresses like ...
Madhura, Ketkar, Shilpee, Dutt
openaire   +2 more sources

Intrinsic or acquired drug resistance and metastasis: Are they linked phenotypes?

Journal of Cellular Biochemistry, 1994
AbstractEvidence is reviewed which suggests a linkage may exist between certain forms of de novo or acquired drug resistance and metastasis. This includes finding that expression of certain dominantly acting mutant oncogenes or tumor suppressor genes, e.g.
R S, Kerbel, H, Kobayashi, C H, Graham
openaire   +2 more sources

DRUG-RESISTANT PATHOGENS IN COMMUNITY- AND HOSPITAL-ACQUIRED PNEUMONIA

Clinics in Chest Medicine, 1999
Antimicrobial resistance has been a problem since the early days of the antibiotic era, but in recent years, this resistance has increased in the hospital and is being recognized more in the community setting. Respiratory pathogens such as S. pneumoniae and H.
J T, Cross, G D, Campbell
openaire   +2 more sources

Drug-resistant Streptococcus pneumoniae in community-acquired pneumonia

Current Infectious Disease Reports, 2003
The emergence of Streptococcus pneumoniae isolates resistant to not only penicillin, but to other antipneumococcal agents as well, has major public health implications. Drug-resistant S. pneumoniae are distributed worldwide, and resistance has become increasingly prevalent in the United States within the past decade.
Michael, Henry, Howard L., Leaf
openaire   +2 more sources

Primary antituberculosis drug resistance and acquired rifampicin resistance in Gujarat, India

Tubercle, 1988
The prevalence of primary antituberculosis drug resistance in Gujarat, as studied between 1983 and 1986, was found to be significantly high, especially for isoniazid (13.9%) and streptomycin (7.4%). Primary rifampicin and pyrazinamide resistance were not detected in any strain. The prevalence of rifampicin resistance among treatment failure and relapse
S S, Trivedi, S G, Desai
openaire   +2 more sources

Risk factors for acquired drug-resistant tuberculosis

European Respiratory Journal, 2013
According to WHO estimates Moldova leads among 27 countries with highest level of MDR-TB, with 27% in new cases and 51% in previously treated, causing 76% of TB-deaths. Patients with treatment failure have the highest rate of MDR. Aim risk factors study for acquired drugresistant-TB (DR-TB). Design Case-control study included 121 new pulmonary TB cases
Evelina Lesnic   +2 more
openaire   +1 more source

Acquired resistance to drugs: the loss of selectivity

1975
A drug designer may build the highest degree of selectivity into his agents, only to see it lost through the development of resistance in his target organism. Drug resistance can arise in at least five distinct ways.
openaire   +1 more source

Somatic Evolution of Acquired Drug Resistance in Cancer

2011
Acquired drug resistance is a central problem in cancer medicine. The diverse molecular mechanisms of acquired drug resistance all arise through the same process of somatic (within-body) cellular evolution. Even targeted drugs are subject to this failure.
openaire   +1 more source

Biofilm-Associated Multi-Drug Resistance in Hospital-Acquired Infections: A Review

Infection and Drug Resistance, 2022
Azanaw Amare, Muluneh Assefa
exaly  

Acquired drug resistance in tuberculosis in Harayana, India.

The Journal of the Association of Physicians of India, 2001
Sputa of 200 treatment failure cases of pulmonary tuberculosis over a period of 1991-1995 were subjected to culture and sensitivity testing against commonly used anti-tuberculosis drugs. Out of 200 cases, 75% revealed resistance to one or more anti-TB drugs, resistance to isoniazid was observed in 72% cases, it was 49% for rifampicin, and 37% for ...
A K, Janmeja, B, Raj
openaire   +1 more source

Home - About - Disclaimer - Privacy